VYNE Therapeutics’ (VYNE) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of VYNE Therapeutics (NASDAQ:VYNE – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $5.75 ...
Rhumbline Advisers Purchases 377 Shares of MercadoLibre, Inc. (NASDAQ:MELI)
Rhumbline Advisers grew its holdings in MercadoLibre, Inc. (NASDAQ:MELI – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm ...
restaurantdive22h
Pinstripes CFO departs, company explores strategic alternative
The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.
MassDevice23h
iRhythm stock rises on Q4 results, on-target FDA remediation efforts
Rhythm (Nasdaq: IRTC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast on Wall ...
Wingstop Stock’s Dip Is an Opportunity, Analyst Says. Plus, Devon Energy, Cadence Design, and More.
Wingstop • WING-Nasdaq Buy • $306.02 on Feb. 19 by Stifel Wingstop reported fourth-quarter earnings per share of $0.92 (Stifel $0.82, Street $0.86), with the upside to the Street estimate driven ...